Animal Growth Promoters and Performance Enhancers Market by Type (Antibiotic and Non-antibiotic), Animal (Poultry, Porcine, Livestock, Aquaculture, and Others), By Geography (North America, Europe, APAC, and RoW) Global Opportunity Analysis and Industry Forecast up to 2026
Animal growth promoters and performance enhancers are type of chemicals and drugs which enhance the growth of animals. Majorly these enhancers help to digest food more effectively and enable animals to grow faster which improves the productivity of the animals. In addition to this these chemicals and drugs provide protection against various type of microbial diseases among animals. Animal growth promoters and performance enhancers market is growing rapidly due to increasing focus on poultry, livestock and agriculture sector across the world. Globally these drugs are used as growth supplements for the animals’ weight increase. These supplements also increase the productivity of the animals by increasing the production of milk ruminants. The global animal growth promoters and performance enhancers market is driven by growing consumption of meat across the world and increasing disposable income of the people. In addition to this the growing population across the world also fuel the demand for food from animal sources.
The animal growth promoters and performance enhancers market report include various segments including
Further, based on the type of chemical/drug segment the non-antibiotic segment accounted largest share in the animal growth promoters and performance enhancers market due to its economic benefits, wide range of substances, environmental sustainability and increasing regulations on antibiotics and hormones.
Moreover, animal growth promoters and performance enhancers market segmented by four regions including North America, Europe, APAC, and RoW. Further the regional analysis includes country level analysis for animal growth promoters and performance enhancers. Asia Pacific is one of the major contributors in the market due to high population as well as large number of animal product companies in this region. North America is accounted second largest share in the market due to increasing awareness about animal growth and performance enhancers and increase in livestock population.
Globally the animal growth promoters and performance enhancers market is growing at CAGR of ~ 6.2% during the forecast period of 2020-2026. There are two major factors are driving the market such as increasing research and development practices to develop antibiotics & hormones and non-antibiotic growth enhancers and rise in climate change and animal epidemics.
Globally these animal growth promoters and performance enhancers plays an important role in agricultural sector due increasing income from the livestock and poultry farming. Which increase the demand for animal growth promoters and performance enhancers. However, the stringent government rules and regulations in some regions for animal growth promoters and performance enhancers hinders the demand for animal growth promoters and performance enhancers.
The report also includes the analysis of major players in the animal growth promoters and performance enhancers market. Some of the major players consists of Elanco Animal Health Inc, Royal DSM N.V, Cargill, Inc, Merck & Co., Inc, Alltech, Inc, Vetoquinol, Bupo Animal Health, Archer-Daniels-Midland Company (ADM), Chr. Hansen, Novus International, Inc, Erber AG, Kemin Industries, Associated British Foods PLC, Nutreco, Erber AG, BASF SE, Phibro Animal Health Corporation, Evonik Industries AG, Bluestar Adisseo Company, Land O’lakes, Inc. and, Lallemand Inc.
Lack of awareness among end-users about animal growth promoters & performance enhancers is the major challenges for the market. However, the increasing investment in research and development activities for the development of natural growth promoters & performance enhancers give new opportunities for the market players in the animal growth promoters and performance enhancers market to solidify their presence. This report will help the market players to understand the key market trends, market dynamics, and dynamic need of the end-users. The qualitative and quantitative analysis enhances the user experience of the report.
The animal growth promoters and performance enhancers market report include various segments including
- Animal Type
- Poultry
- Swine,
- Livestock
- Aquatic animals
- Type of Drug/Chemicals
- Antibiotics
- Non-Antibiotics
- Prebiotics & Probiotics
- Phytogenics
- Feed Enzymes
- Hormones
- Region
- North America
- Europe
- APAC
- RoW
Further, based on the type of chemical/drug segment the non-antibiotic segment accounted largest share in the animal growth promoters and performance enhancers market due to its economic benefits, wide range of substances, environmental sustainability and increasing regulations on antibiotics and hormones.
Moreover, animal growth promoters and performance enhancers market segmented by four regions including North America, Europe, APAC, and RoW. Further the regional analysis includes country level analysis for animal growth promoters and performance enhancers. Asia Pacific is one of the major contributors in the market due to high population as well as large number of animal product companies in this region. North America is accounted second largest share in the market due to increasing awareness about animal growth and performance enhancers and increase in livestock population.
Globally the animal growth promoters and performance enhancers market is growing at CAGR of ~ 6.2% during the forecast period of 2020-2026. There are two major factors are driving the market such as increasing research and development practices to develop antibiotics & hormones and non-antibiotic growth enhancers and rise in climate change and animal epidemics.
Globally these animal growth promoters and performance enhancers plays an important role in agricultural sector due increasing income from the livestock and poultry farming. Which increase the demand for animal growth promoters and performance enhancers. However, the stringent government rules and regulations in some regions for animal growth promoters and performance enhancers hinders the demand for animal growth promoters and performance enhancers.
The report also includes the analysis of major players in the animal growth promoters and performance enhancers market. Some of the major players consists of Elanco Animal Health Inc, Royal DSM N.V, Cargill, Inc, Merck & Co., Inc, Alltech, Inc, Vetoquinol, Bupo Animal Health, Archer-Daniels-Midland Company (ADM), Chr. Hansen, Novus International, Inc, Erber AG, Kemin Industries, Associated British Foods PLC, Nutreco, Erber AG, BASF SE, Phibro Animal Health Corporation, Evonik Industries AG, Bluestar Adisseo Company, Land O’lakes, Inc. and, Lallemand Inc.
Lack of awareness among end-users about animal growth promoters & performance enhancers is the major challenges for the market. However, the increasing investment in research and development activities for the development of natural growth promoters & performance enhancers give new opportunities for the market players in the animal growth promoters and performance enhancers market to solidify their presence. This report will help the market players to understand the key market trends, market dynamics, and dynamic need of the end-users. The qualitative and quantitative analysis enhances the user experience of the report.
- The competitive analysis of the major players enables users to understand the dynamic strategies such as product innovation, partnerships, merger & acquisitions and joint ventures of the key players
- This report also provides the SWOT analysis, portfolio analysis, capability analysis of the leading players
- The report will also help the research organization of Animal Growth Promoters and Performance Enhancers to support their drug discovery and development activities
- Quantitative analysis of the market enables users to understand the actual facts of the market across four major regions
1. EXECUTIVE SUMMARY
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. ANIMAL TYPE: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Poultry
5.3. Swine
5.4. Livestock
5.5. Aquatic animals
5.6. Other animals
6. TYPE OF DRUG/CHEMICALS: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Antibiotics
6.3. Non-Antibiotics
7. GEOGRAPHY: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia Pacific
7.5. Rest of the World
8. COMPETITIVE LANDSCAPE
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. VENDOR PROFILES
9.1. Cargill, Inc.
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. Zoetis Inc.
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. Royal DSM N.V.
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. Elanco Animal Health
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. Alltech Corporation
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.6. Archer Daniels Midland Company
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. Boehringer Ingelheim Animal Health GmbH
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. Evonik Industries AG
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. Kemin Industries, Inc.
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. Phibro Animal Health Corporation
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy
10. ANALYST OPINION
11. ANNEXURE
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations
Tables
TABLE 1. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 2. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR POULTRY, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 3. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR SWINE, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 4. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR LIVESTOCK, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 5. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR AQUATIC ANIMALS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 6. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR OTHER ANIMALS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 7. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 8. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR ANTIBIOTICS, 2022-2028 (USD BILLION)
TABLE 9. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR NON-ANTIBIOTICS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 10. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 11. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 12. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 13. U.S ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 14. U.S ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 15. CANADA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 16. CANADA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 17. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 18. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 19. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 20. GERMANY ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 21. GERMANY ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 22. U.K ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 23. U.K ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 24. FRANCE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 25. FRANCE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 26. ITALY ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 27. ITALY ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 28. SPAIN ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 29. SPAIN ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 30. ROE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 31. ROE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 32. ASIA PACIFC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 33. ASIA PACIFC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 34. ASIA PACIFC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 35. CHINA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 36. CHINA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 37. INDIA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 38. INDIA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 39. JAPAN ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 40. JAPAN ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 41. REST OF APAC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 42. REST OF APAC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 43. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 44. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 45. CARGILL, INC.: FINANCIALS
TABLE 46. CARGILL, INC.: PRODUCT AND SERVICES
TABLE 47. CARGILL, INC.: RECENT DEVELOPMENTS
TABLE 48. CARGILL, INC.: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 49. ZOETIS INC.: FINANCIALS
TABLE 50. ZOETIS INC.: PRODUCT AND SERVICES
TABLE 51. ZOETIS INC.: RECENT DEVELOPMENTS
TABLE 52. ZOETIS INC.: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 53. ROYAL DSM N.V.: FINANCIALS
TABLE 54. ROYAL DSM N.V.: PRODUCT AND SERVICES
TABLE 55. ROYAL DSM N.V.: RECENT DEVELOPMENTS
TABLE 56. ROYAL DSM N.V.: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 57. ELANCO ANIMAL HEALTH: FINANCIALS
TABLE 58. ELANCO ANIMAL HEALTH: PRODUCT AND SERVICES
TABLE 59. ELANCO ANIMAL HEALTH: RECENT DEVELOPMENTS
TABLE 60. ELANCO ANIMAL HEALTH: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 61. ALLTECH CORPORATION: FINANCIALS
TABLE 62. ALLTECH CORPORATION: PRODUCT AND SERVICES
TABLE 63. ALLTECH CORPORATION: RECENT DEVELOPMENTS
TABLE 64. ALLTECH CORPORATION: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 65. ARCHER DANIELS MIDLAND COMPANY: FINANCIALS
TABLE 66. ARCHER DANIELS MIDLAND COMPANY: PRODUCT AND SERVICES
TABLE 67. ARCHER DANIELS MIDLAND COMPANY: RECENT DEVELOPMENTS
TABLE 68. ARCHER DANIELS MIDLAND COMPANY: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 69. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH: FINANCIALS
TABLE 70. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH: PRODUCT AND SERVICES
TABLE 71. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH: RECENT DEVELOPMENTS
TABLE 72. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 73. EVONIK INDUSTRIES AG: FINANCIALS
TABLE 74. EVONIK INDUSTRIES AG: PRODUCT AND SERVICES
TABLE 75. EVONIK INDUSTRIES AG: RECENT DEVELOPMENTS
TABLE 76. EVONIK INDUSTRIES AG: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 77. KEMIN INDUSTRIES, INC.: FINANCIALS
TABLE 78. KEMIN INDUSTRIES, INC.: PRODUCT AND SERVICES
TABLE 79. KEMIN INDUSTRIES, INC.: RECENT DEVELOPMENTS
TABLE 80. KEMIN INDUSTRIES, INC.: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 81. PHIBRO ANIMAL HEALTH CORPORATION: FINANCIALS
TABLE 82. PHIBRO ANIMAL HEALTH CORPORATION: PRODUCT AND SERVICES
TABLE 83. PHIBRO ANIMAL HEALTH CORPORATION: RECENT DEVELOPMENTS
TABLE 84. PHIBRO ANIMAL HEALTH CORPORATION: APPLICATION/SERVICE PROVIDER PORTFOLIO
Charts
CHART. 1. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 2. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR POULTRY, BY GEOGRAPHY, 2022-2028 (USD BILLION)
CHART. 3. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR SWINE, BY GEOGRAPHY, 2022-2028 (USD BILLION)
CHART. 4. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR LIVESTOCK, BY GEOGRAPHY, 2022-2028 (USD BILLION)
CHART. 5. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR AQUATIC ANIMALS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
CHART. 6. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR OTHER ANIMALS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
CHART. 7. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 8. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR ANTIBIOTICS, 2022-2028 (USD BILLION)
CHART. 9. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR NON-ANTIBIOTICS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
CHART. 10. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
CHART. 11. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 12. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 13. U.S ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 14. U.S ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 15. CANADA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 16. CANADA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 17. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
CHART. 18. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 19. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 20. GERMANY ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 21. GERMANY ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 22. U.K ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 23. U.K ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 24. FRANCE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 25. FRANCE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 26. ITALY ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 27. ITALY ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 28. SPAIN ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 29. SPAIN ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 30. ROE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 31. ROE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 32. ASIA PACIFC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
CHART. 33. ASIA PACIFC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 34. ASIA PACIFC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 35. CHINA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 36. CHINA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 37. INDIA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 38. INDIA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 39. JAPAN ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 40. JAPAN ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 41. REST OF APAC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 42. REST OF APAC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 43. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 44. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. ANIMAL TYPE: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Poultry
5.3. Swine
5.4. Livestock
5.5. Aquatic animals
5.6. Other animals
6. TYPE OF DRUG/CHEMICALS: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Antibiotics
6.3. Non-Antibiotics
7. GEOGRAPHY: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia Pacific
7.5. Rest of the World
8. COMPETITIVE LANDSCAPE
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. VENDOR PROFILES
9.1. Cargill, Inc.
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. Zoetis Inc.
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. Royal DSM N.V.
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. Elanco Animal Health
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. Alltech Corporation
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.6. Archer Daniels Midland Company
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. Boehringer Ingelheim Animal Health GmbH
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. Evonik Industries AG
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. Kemin Industries, Inc.
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. Phibro Animal Health Corporation
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy
10. ANALYST OPINION
11. ANNEXURE
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations
Tables
TABLE 1. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 2. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR POULTRY, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 3. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR SWINE, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 4. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR LIVESTOCK, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 5. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR AQUATIC ANIMALS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 6. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR OTHER ANIMALS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 7. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 8. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR ANTIBIOTICS, 2022-2028 (USD BILLION)
TABLE 9. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR NON-ANTIBIOTICS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
TABLE 10. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 11. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 12. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 13. U.S ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 14. U.S ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 15. CANADA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 16. CANADA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 17. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 18. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 19. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 20. GERMANY ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 21. GERMANY ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 22. U.K ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 23. U.K ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 24. FRANCE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 25. FRANCE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 26. ITALY ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 27. ITALY ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 28. SPAIN ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 29. SPAIN ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 30. ROE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 31. ROE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 32. ASIA PACIFC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
TABLE 33. ASIA PACIFC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 34. ASIA PACIFC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 35. CHINA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 36. CHINA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 37. INDIA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 38. INDIA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 39. JAPAN ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 40. JAPAN ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 41. REST OF APAC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 42. REST OF APAC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 43. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
TABLE 44. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
TABLE 45. CARGILL, INC.: FINANCIALS
TABLE 46. CARGILL, INC.: PRODUCT AND SERVICES
TABLE 47. CARGILL, INC.: RECENT DEVELOPMENTS
TABLE 48. CARGILL, INC.: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 49. ZOETIS INC.: FINANCIALS
TABLE 50. ZOETIS INC.: PRODUCT AND SERVICES
TABLE 51. ZOETIS INC.: RECENT DEVELOPMENTS
TABLE 52. ZOETIS INC.: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 53. ROYAL DSM N.V.: FINANCIALS
TABLE 54. ROYAL DSM N.V.: PRODUCT AND SERVICES
TABLE 55. ROYAL DSM N.V.: RECENT DEVELOPMENTS
TABLE 56. ROYAL DSM N.V.: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 57. ELANCO ANIMAL HEALTH: FINANCIALS
TABLE 58. ELANCO ANIMAL HEALTH: PRODUCT AND SERVICES
TABLE 59. ELANCO ANIMAL HEALTH: RECENT DEVELOPMENTS
TABLE 60. ELANCO ANIMAL HEALTH: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 61. ALLTECH CORPORATION: FINANCIALS
TABLE 62. ALLTECH CORPORATION: PRODUCT AND SERVICES
TABLE 63. ALLTECH CORPORATION: RECENT DEVELOPMENTS
TABLE 64. ALLTECH CORPORATION: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 65. ARCHER DANIELS MIDLAND COMPANY: FINANCIALS
TABLE 66. ARCHER DANIELS MIDLAND COMPANY: PRODUCT AND SERVICES
TABLE 67. ARCHER DANIELS MIDLAND COMPANY: RECENT DEVELOPMENTS
TABLE 68. ARCHER DANIELS MIDLAND COMPANY: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 69. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH: FINANCIALS
TABLE 70. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH: PRODUCT AND SERVICES
TABLE 71. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH: RECENT DEVELOPMENTS
TABLE 72. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 73. EVONIK INDUSTRIES AG: FINANCIALS
TABLE 74. EVONIK INDUSTRIES AG: PRODUCT AND SERVICES
TABLE 75. EVONIK INDUSTRIES AG: RECENT DEVELOPMENTS
TABLE 76. EVONIK INDUSTRIES AG: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 77. KEMIN INDUSTRIES, INC.: FINANCIALS
TABLE 78. KEMIN INDUSTRIES, INC.: PRODUCT AND SERVICES
TABLE 79. KEMIN INDUSTRIES, INC.: RECENT DEVELOPMENTS
TABLE 80. KEMIN INDUSTRIES, INC.: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 81. PHIBRO ANIMAL HEALTH CORPORATION: FINANCIALS
TABLE 82. PHIBRO ANIMAL HEALTH CORPORATION: PRODUCT AND SERVICES
TABLE 83. PHIBRO ANIMAL HEALTH CORPORATION: RECENT DEVELOPMENTS
TABLE 84. PHIBRO ANIMAL HEALTH CORPORATION: APPLICATION/SERVICE PROVIDER PORTFOLIO
Charts
CHART. 1. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 2. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR POULTRY, BY GEOGRAPHY, 2022-2028 (USD BILLION)
CHART. 3. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR SWINE, BY GEOGRAPHY, 2022-2028 (USD BILLION)
CHART. 4. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR LIVESTOCK, BY GEOGRAPHY, 2022-2028 (USD BILLION)
CHART. 5. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR AQUATIC ANIMALS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
CHART. 6. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR OTHER ANIMALS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
CHART. 7. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 8. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR ANTIBIOTICS, 2022-2028 (USD BILLION)
CHART. 9. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE FOR NON-ANTIBIOTICS, BY GEOGRAPHY, 2022-2028 (USD BILLION)
CHART. 10. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
CHART. 11. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 12. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 13. U.S ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 14. U.S ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 15. CANADA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 16. CANADA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 17. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
CHART. 18. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 19. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 20. GERMANY ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 21. GERMANY ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 22. U.K ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 23. U.K ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 24. FRANCE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 25. FRANCE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 26. ITALY ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 27. ITALY ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 28. SPAIN ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 29. SPAIN ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 30. ROE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 31. ROE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 32. ASIA PACIFC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY COUNTRY, 2022-2028 (USD BILLION)
CHART. 33. ASIA PACIFC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 34. ASIA PACIFC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 35. CHINA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 36. CHINA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 37. INDIA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 38. INDIA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 39. JAPAN ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 40. JAPAN ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 41. REST OF APAC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 42. REST OF APAC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)
CHART. 43. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY ANIMAL TYPE, 2022-2028 (USD BILLION)
CHART. 44. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY TYPE OF DRUG/CHEMICALS, 2022-2028 (USD BILLION)